We are live on ! Find out more
MSKCC

Memorial Sloan Kettering Cancer Center Portfolio holdings

AUM $24.6M
1-Year Est. Return 10.16%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+10.16%
3 Year Est. Return
-14.79%
5 Year Est. Return
10 Year Est. Return
AUM
$31.7M
AUM Growth
-$929K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 29.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDX icon
1
VanEck Gold Miners ETF
GDX
$27.4B
$22.2M 70.19%
738,500
ORIC icon
2
Oric Pharmaceuticals
ORIC
$1.4B
$4.67M 14.75%
602,272
CRBU icon
3
Caribou Biosciences
CRBU
$164M
$2.31M 7.3%
544,196
YMAB
4
DELISTED
Y-mAbs Therapeutics
YMAB
$1.3M 4.1%
191,176
ILMN icon
5
Illumina
ILMN
$28.4B
$1.16M 3.66%
6,360

Similar funds

Memorial Sloan Kettering Cancer Center's Q2 2023 Portfolio in Review

As of Q2 2023, Memorial Sloan Kettering Cancer Center held 5 positions worth $31.7M, down 2.8% from $32.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 0%. Memorial Sloan Kettering Cancer Center opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 27% a quarter earlier.

  • Memorial Sloan Kettering Cancer Center's ten largest holdings make up 100% of its $31.7M portfolio in Q2 2023.
  • Memorial Sloan Kettering Cancer Center opened 0 new positions and closed 0 in Q2 2023.
  • Memorial Sloan Kettering Cancer Center's portfolio value fell 2.8% quarter-over-quarter to $31.7M.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q2 2023, filed 14 Aug 2023.